DE3876788D1 - Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff. - Google Patents

Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.

Info

Publication number
DE3876788D1
DE3876788D1 DE8888909786T DE3876788T DE3876788D1 DE 3876788 D1 DE3876788 D1 DE 3876788D1 DE 8888909786 T DE8888909786 T DE 8888909786T DE 3876788 T DE3876788 T DE 3876788T DE 3876788 D1 DE3876788 D1 DE 3876788D1
Authority
DE
Germany
Prior art keywords
peptide
product containing
interferon
urine
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888909786T
Other languages
English (en)
Other versions
DE3876788T2 (de
Inventor
Chantal Damais
Danielle Lando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of DE3876788D1 publication Critical patent/DE3876788D1/de
Publication of DE3876788T2 publication Critical patent/DE3876788T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8888909786T 1987-10-08 1988-10-06 Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff. Expired - Lifetime DE3876788T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8713886A FR2621488B1 (fr) 1987-10-08 1987-10-08 Produit comprenant a titre de principes actifs a) un peptide ayant une activite du type de celle de l'interferon gamma humain, b) l'hyfroxyuree
PCT/FR1988/000496 WO1989003224A1 (fr) 1987-10-08 1988-10-06 Produit comprenant a titre de principes actifs: a) un peptide ayant une activite du type de celle de l'interferon gamma humain, b) l'hydroxyuree

Publications (2)

Publication Number Publication Date
DE3876788D1 true DE3876788D1 (de) 1993-01-28
DE3876788T2 DE3876788T2 (de) 1993-07-01

Family

ID=9355622

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888909786T Expired - Lifetime DE3876788T2 (de) 1987-10-08 1988-10-06 Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.

Country Status (7)

Country Link
EP (1) EP0336958B1 (de)
JP (1) JP2537677B2 (de)
AT (1) ATE83382T1 (de)
CA (1) CA1327745C (de)
DE (1) DE3876788T2 (de)
FR (1) FR2621488B1 (de)
WO (1) WO1989003224A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2704546B2 (ja) * 1989-04-04 1998-01-26 光利 太良 Ａｔｌｌ治療用吸入剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968249A (en) * 1963-01-22 1976-07-06 E. R. Squibb & Sons, Inc. Method of treating malignant neoplastic disease

Also Published As

Publication number Publication date
FR2621488B1 (fr) 1990-02-02
EP0336958A1 (de) 1989-10-18
DE3876788T2 (de) 1993-07-01
CA1327745C (fr) 1994-03-15
JPH02501484A (ja) 1990-05-24
FR2621488A1 (fr) 1989-04-14
WO1989003224A1 (fr) 1989-04-20
JP2537677B2 (ja) 1996-09-25
EP0336958B1 (de) 1992-12-16
ATE83382T1 (de) 1993-01-15

Similar Documents

Publication Publication Date Title
DE3689974D1 (de) Arzneimittel zur Behandlung von Emesis.
DE68909219D1 (de) Behandlung von obesitas.
DE3764926D1 (de) Schaedlingsbekaempfungs- und pflanzenbehandlungsmittel.
IT8619338A0 (it) Peptide sintetico ad attivita'interleukina 1 umana.
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
NO880626L (no) Fenol-stabiliserte mikrobiocidpreparater.
DE3686018D1 (de) Betriebsfuehrung von hardwaremitteln.
EP0151246A3 (en) Polypeptide inhibitor of the activity of alpha-amylase, process for its preparation, its use, and pharmaceutical preparations
DE3587741D1 (de) Behandlung von Hautkrankheiten.
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
DE68909970D1 (de) Hautbehandlungsmittel.
DE3777861D1 (de) Behandlung von gasen.
ATE112172T1 (de) Targetformer von antitumor-methyltrithioagenzien.
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
DE68912278D1 (de) Verformung von verbundenen abrasiven Produkten.
DE3584926D1 (de) Behandlung von oedemen mit hohem proteingehalt durch direktes aufbringen von benzopyronen.
DE3876788D1 (de) Erzeugnis, enthaltend als wirkstoffe: a) ein peptid mit einer wirkung von der art des gamma-hu-interferons b) hydroxyharnstoff.
DE3761048D1 (de) Umsetzungsprodukte von bis-glycidylthioethern.
DE68918742D1 (de) Polyanhydridmodifizierte Addukte oder Reaktionsprodukte und diese enthaltende ölige Zubereitungen.
DE3675720D1 (de) Behandlung von material aus lignocellulose.
DE68914161D1 (de) Herstellung von prodrogen.
ATE74537T1 (de) Behandlung von gebrauchten antimonhalidkatalysatoren.
DE3783218D1 (de) Fermentationsanaloge von virginiamycin-m1.
DE3780388D1 (de) Fsh-stimulierendes peptid.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HOECHST MARION ROUSSEL, PUTEAUX, FR

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY CEDEX, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN